Assessing Specific Cognitive Deficits Associated with Dementia in Older Adults with Down Syndrome: Use and Validity of the Arizona Cognitive Test Battery (ACTB)
Open Access
- 12 May 2016
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 11 (5) , e0153917
Abstract
Down syndrome is associated with specific cognitive deficits. Alongside this, older adults with Down syndrome are a high risk group for dementia. The Arizona Cognitive Test Battery (ACTB), a cognitive assessment battery specifically developed for use with individuals with Down syndrome, has been proposed for use as outcome measures for clinical trials in this population. It has not been validated in older adults with Down syndrome. This study aims to assess the use and validity of the ACTB in older adults with Down syndrome. Participants with Down syndrome aged 45 and over were assessed using the ACTB, standard tabletop tests and informant ratings. Assessment outcomes of 49 participants were analysed. Of these, 19 (39%) had a diagnosis of dementia or possible dementia. Most participants were able to attempt most of the tasks, although some tasks had high floor effects (including CANTAB Intra-Extra Dimensional shift stages completed and Modified Dots Task). Of the ACTB tasks, statistically significant differences were observed between the dementia and no dementia groups on CANTAB Simple Reaction Time median latency, NEPSY Visuomotor Precision—Car and Motorbike and CANTAB Paired Associates Learning stages completed. No significant differences were observed for CANTAB Intra-Extra Dimensional Shift, Modified Dots Task, Finger Sequencing, NEPSY Visuomotor precision—Train and Car and CANTAB Paired Associates Learning first trial memory score. Several of the tasks in the ACTB can be used in older adults with Down syndrome and have mild to moderate concurrent validity when compared to tabletop tests and informant ratings, although this varies on a test by test basis. Overall, scores for a number of tests in the ACTB were similar when comparing dementia and no dementia groups of older adults with Down syndrome, suggesting that it would not be an appropriate outcome measure of cognitive function for clinical trials of dementia treatments without further modification and validation.Keywords
This publication has 45 references indexed in Scilit:
- Antagonism of NMDA receptors as a potential treatment for Down syndrome: a pilot randomized controlled trialTranslational Psychiatry, 2012
- Memantine for dementia in adults older than 40 years with Down's syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trialThe Lancet, 2012
- Neuropsychological effects of second language exposure in Down syndromeJournal of Intellectual Disability Research, 2011
- Updated national birth prevalence estimates for selected birth defects in the United States, 2004–2006Birth Defects Research Part A: Clinical and Molecular Teratology, 2010
- Development and validation of the Arizona Cognitive Test Battery for Down syndromeJournal of Neurodevelopmental Disorders, 2010
- Prevalence of dementia in intellectual disability using different diagnostic criteriaThe British Journal of Psychiatry, 2007
- Early Detection and Differential Diagnosis of Alzheimer’s Disease and Depression with Neuropsychological TasksDementia and Geriatric Cognitive Disorders, 2001
- Sequence of cognitive decline in dementia in adults with Down's syndromeJournal of Intellectual Disability Research, 2000
- The Tower of LondonDX: A Standardized Approach to Assessing Executive Functioning in ChildrenArchives of Clinical Neuropsychology, 1998
- Further evaluation of the Dementia Questionnaire for Persons with Mental Retardation (DMR)Journal of Intellectual Disability Research, 1996